CoChat

Telomere length in blood cells and breast cancer risk: investigations in two case–control studies

Open access
Zheng, Yun-Ling, Ambrosone, Christine, Byrne, Celia, Davis, Warren, Nesline, Mary, McCann, Susan E. · 2010 · Breast Cancer Research and Treatment
Cited by 61

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Telomere dysfunction, which leads to genomic instability, is hypothesized to play a causal role in the development of breast cancer. However, the few epidemiologic studies that assessed the relationship between telomere length in blood cells and breast cancer risk have been inconsistent. We conducted two case–control studies to further understand the role of telomere length and breast cancer risk. Overall telomere lengths were measured by telomere quantitative fluorescent in situ hybridization (TQ-FISH) and telomere quantitative real-time PCR (TQ-PCR). The associations between telomere length in blood leukocytes and risk of breast cancer were examined in two breast cancer case–control studies that were conducted at Roswell Park Cancer Institute (RPCI) and Lombardi Comprehensive Cancer Center (LCCC). Using the 50th percentile value in controls as a cut point, women who had shorter telomere length were not at significantly increased risk of breast cancer compared with women who had longer telomere length in the RPCI study (odds ratio [OR] = 1.34, 95% confidence interval [CI] = 0.84–2.12), in the LCCC study (OR = 1.18, 95% CI = 0.73–1.91), or in the combined RPCI and LCCC studies (OR = 1.23, 95% CI = 0.89–1.71). There was no significant dose–response relationship across quartiles of telomere length and no significant difference when comparing women in the lowest to highest quartile of telomere length. Overall telomere length in blood leukocytes was not significantly associated with the risk of breast cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10549-009-0440-z

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 61

Metadata

Authors
Zheng, Y.-L., Ambrosone, C., Byrne, C., Davis, W., Nesline, M., & McCann, S. E.
Venue
Breast Cancer Research and Treatment
Published
2009-06-19
Volume
120
Issue
3
Pages
769-775
ISSN
  • 0167-6806 (ISSN-L)
  • 1573-7217
OpenAlex
W2076237535
Cited by
61
References
7
FWCI
3.54
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Telomere length in blood cells and breast cancer risk: investigations in two case–control studies. https://app.cochat.ai/papers/10.1007/s10549-009-0440-z
The paper
Zheng, Y.-L., Ambrosone, C., Byrne, C., Davis, W., Nesline, M., & McCann, S. E. (2010). Telomere length in blood cells and breast cancer risk: investigations in two case–control studies. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-009-0440-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.